Neonatal circulatory failure in the first two days after birth leads to impaired blood flow and can result in brain injury and decreased neurodevelopment. A European consortium is addressing the efficacy and safety of the drug dobutamine, which is currently used to treat systemic hypotension in infants.
Further information: cordis.europa.eu